A separate study from Mass General Brigham found that women who discontinued GLP-1 medications before or early in pregnancy gained an average of 7.2 pounds more during pregnancy and experienced higher rates of gestational diabetes, hypertensive disorders, and preterm birth
At TrimBody M.D., every treatment is unique so they can be safe and help you reach your goals faster
The improved overall metabolic landscape explains why these medications are known to improve conditions associated with insulin resistance, like type 2 diabetes, cardiovascular disease, chronic kidney disease, and, obviously, obesity
Together, they create something that hasnt existed before for people on these medicationsa continuous record of whats happening in your body between the moments you see your care team
Always proceed under the guidance of a health care professional
Other researchers noted that direct comparisons with existing drugs such as semaglutide and tirzepatide have not yet been carried out